Infleqtion, Inc. (INFQ) director logs option exercise and 50,000-share sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Infleqtion, Inc. director Kristina M. Johnson reported option exercises and share sales involving a net sale of 50,000 shares of Common Stock. On 2026-05-28, she exercised stock options to acquire 30,000 shares at an exercise price of $0.90 per share and then sold 30,000 shares in an open-market sale at a weighted average price of about $16.45 per share. On the same date, 20,000 additional shares were sold in open-market transactions at a weighted average price of about $18.00 per share by Catalyzer Ventures, LP Fund I, where she is a general partner and disclaims beneficial ownership except for her pecuniary interest. Following these transactions, she holds 30,000 shares directly, 13,120 shares indirectly through Catalyzer, and stock options for 343,458 shares expiring on 2034-06-05.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 50,000 shares ($853,500)
Net Sell
4 txns
Insider
JOHNSON KRISTINA M
Role
null
Sold
50,000 shs ($854K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | -- |
| Sale | Common Stock | 20,000 | $18.00 | $360K |
| Exercise | Common Stock | 30,000 | $0.90 | $27K |
| Sale | Common Stock | 30,000 | $16.45 | $494K |
Holdings After Transaction:
Stock Option (Right to Buy) — 343,458 shares (Direct, null);
Common Stock — 13,120 shares (Indirect, See footnote);
Common Stock — 30,000 shares (Direct, null)
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.85 to $18.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Held directly by Catalyzer Ventures, LP Fund I ("Catalyzer"). Dr. Johnson is a general partner of Catalyzer. Dr. Johnson disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.45 to $16.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares vest on a monthly basis beginning on June 1, 2024 with respect to 1/36 of the total number of shares until such time as the option is 100% vested, subject to the continuous service of the Reporting Person as of each such date.
Key Figures
Shares sold directly: 30,000 shares
Shares sold via Catalyzer: 20,000 shares
Options exercised: 30,000 shares at $0.90/share
+5 more
8 metrics
Shares sold directly
30,000 shares
Common Stock open-market sale at ~$16.45 on May 28, 2026
Shares sold via Catalyzer
20,000 shares
Indirect Common Stock sale at ~$18.00 on May 28, 2026
Options exercised
30,000 shares at $0.90/share
Stock Option (Right to Buy) exercise on May 28, 2026
Net shares sold
50,000 shares
Net-sell direction from transaction summary
Direct holdings after trades
30,000 shares
Common Stock directly held following transactions
Indirect holdings after trades
13,120 shares
Common Stock held indirectly through Catalyzer Ventures, LP Fund I
Remaining stock options
343,458 options
Stock options for Common Stock expiring June 5, 2034
Sale price range (20,000 shares)
$17.85–$18.05
Weighted-average sale range noted in footnote F1
Key Terms
open-market sale, Stock Option (Right to Buy), weighted average price, beneficial ownership, +1 more
5 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"Dr. Johnson disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein."
FAQ
What insider transactions did Infleqtion, Inc. (INFQ) director Kristina Johnson report?
Kristina Johnson reported exercising options for 30,000 Infleqtion shares at $0.90 and selling 50,000 shares in total. This included 30,000 directly sold around $16.45 and 20,000 sold around $18.00 through Catalyzer Ventures, LP Fund I.
What stock options did Kristina Johnson exercise in Infleqtion (INFQ)?
She exercised stock options covering 30,000 Infleqtion shares at an exercise price of $0.90 per share. After this transaction, options covering 343,458 shares of Common Stock remained outstanding, with an expiration date of June 5, 2034.
What is Catalyzer Ventures’ role in the Infleqtion (INFQ) insider sale?
Catalyzer Ventures, LP Fund I sold 20,000 Infleqtion shares at a weighted average price around $18.00. Johnson is a general partner of Catalyzer and disclaims beneficial ownership of these securities except to the extent of her pecuniary interest in the partnership.